Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer.

Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...

There isn’t a single answer to what causes pancreatic cancer because it involves multiple factors. Here’s what science knows ...

Harvard Medical School unveils an AI digital pathology tool that outperforms state-of-the-art deep learning methods, ...

An immune protein could hold the key to developing new drugs to help fight bowel cancer, according to new research from The ...

Analysis - Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also particularly challenging to treat. Physiologist Anna-Mart ...

Triple-negative breast cancer (TNBC): The breast tissue lacks estrogen receptors, progesterone receptors, and HER2 protein receptors that control how cells grow and divide. Triple-negative breast ...

Wolpin’s team used AI to find patterns in over nine million patients, looking at medical records, family history and genetic ...

Breast cancer is a major global health issue, with 2.3 million new cases in 2022. In The Bahamas, the situation is particularly alarming, as 300 to 500 women are diagnosed ...

Claudin 18.2 testing is a crucial step in determining whether Vyloy will be an effective treatment option for you patients ...